logo

Arcutis Biotherapeutics Inc (ARQT) Stock: Uncovering 52-Week Market Trends

PNC Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Arcutis Biotherapeutics Inc’s current trading price is -33.77% away from its 52-week high, while its distance from the 52-week low is 479.55%. The stock’s price range for this period has been between $1.76 and $15.40 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 4.16 million for the day, a number notably lower than the average daily volume of 4.67 million over the last three months.

Arcutis Biotherapeutics Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $15.40 on 04/13/23 and the lowest value was $1.76 on 12/01/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Arcutis Biotherapeutics Inc (ARQT) has experienced a quarterly rise of 175.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.17B and boasts a workforce of 296 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 6.33, with a change in price of +8.25. Similarly, Arcutis Biotherapeutics Inc recorded 5,204,903 in trading volume during the last 100 days, posting a change of +423.08%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ARQT stands at 2.32. Similarly, the long-term debt-to-equity ratio is also 2.31.

ARQT Stock Stochastic Average

Arcutis Biotherapeutics Inc’s raw stochastic average for the past 50 days is presently 61.87%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 27.21%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 58.42% and 74.12%, respectively.

ARQT Stock Price Performance Analysis

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. Until today this year the stock’s price performance recorded an increase of 215.79%. However, over the last six months, the performance has been weaker by 126.16%. The price of ARQT decreased -7.78% over the last 30 days. And in the last five days, it has fallen by -10.05%.